ALFA Filings
Every announcement, straight from the exchange
Every Aptus Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Aptus Pharma Limited submitted the Regulation 74(5) compliance certificate for the quarter and half-year ended 30th September 2026, as received from its registrar.
Aptus Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.
Aptus Pharma Ltd informed BSE that Regulation 24A of SEBI (LODR) Regulations, 2015, regarding the Annual Secretarial Compliance Report, is not applicable to the company. As an entity listed on the SME Exchange, it falls under the exemptions provided in Regulation 15(2)(b).